Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Inventory (2017 - 2025)

Ptc Therapeutics (PTCT) has 9 years of Change in Inventory data on record, last reported at $26.8 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 341.56% year-over-year to $26.8 million; the TTM value through Dec 2025 reached $53.9 million, up 974.37%, while the annual FY2025 figure was $53.9 million, 974.37% up from the prior year.
  • Change in Inventory reached $26.8 million in Q4 2025 per PTCT's latest filing, up from $18.5 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $26.8 million in Q4 2025 and bottomed at -$11.1 million in Q4 2024.
  • Average Change in Inventory over 5 years is $3.0 million, with a median of $735500.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: plummeted 1824.51% in 2021, then surged 1504.64% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $676000.0 in 2021, then surged by 772.78% to $5.9 million in 2022, then crashed by 200.64% to -$5.9 million in 2023, then tumbled by 86.7% to -$11.1 million in 2024, then soared by 341.56% to $26.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $26.8 million in Q4 2025, $18.5 million in Q3 2025, and $10.8 million in Q2 2025.